(WASHINGTON) – Francine Garrett-Bakelman, MD, PhD, has been selected to receive the 2013 ASH-AMFDP Award to conduct research on the clinical and biological significance of epigenetic and genetic factors that characterize acute myeloid leukemia (AML) in patients age 60 and older. This award, designed to help increase the number of underrepresented minority scholars in the field of hematology, is the result of a partnership between the American Society of Hematology (ASH) and the Harold Amos Medical Faculty Development Program (AMFDP) of the Robert Wood Johnson Foundation. It provides four years of support, including an annual stipend of up to $75,000 and an annual research grant of $30,000.
Dr. Garrett-Bakelman is an Instructor of Medicine at Weill Cornell Medical College in New York who conducts research on myeloid malignancies in the laboratory of Ari Melnick, MD. She also serves as an Assistant Attending Physician at the New York Presbyterian Hospital where she is part of the Leukemia Program. The research supported by Dr. Garrett-Bakelman’s 2013 ASH-AMFDP Award will aim to define the molecular basis of and comprehensive biological picture for elderly AML, examining recurrent mutations, transcriptome, and methylome patterns and implementing computational approaches for pattern recognition and integrative analysis of reproducible genetic, epigenetic, and transcriptional lesions characterizing the disorder. As a physician-scientist, Dr. Garret-Bakelman aims to use her observations to help identify molecular targets for potential therapeutic interventions.
Dr. Garrett-Bakelman received her medical and post-doctorate degrees from the Albert Einstein College of Medicine of Yeshiva University in New York. She completed her Internship and Residency in Internal Medicine as well as her Hematology and Medical Oncology Fellowship training at the New York Presbyterian Hospital/Weill Cornell Medical College in New York. Dr. Garrett-Bakelman participated in the 2012 Translational Research Training in Hematology program jointly supported by the European Hematology Association (EHA) and the American Society of Hematology.
Reporters who wish to arrange an interview with Dr. Garrett-Bakelman may contact Andrea Slesinski at 202-552-4927 or email@example.com.
The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. The official journal of ASH is Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online.
back to top